Service Header - Strategy

Strategy

RELIABLE METHODS FOR OPTIMISED STRATEGIC PLANS

MediTech Access provides a wide range of Market Access and HEOR support solutions for France, Belgium, Switzerland and more generally Europe, to guide you in the best early-funding or reimbursement strategies for your healthcare solution, whether it is a medical device, a diagnostic, a connected software or a drug. We propose tailored services, from face-to-face strategic consultations to complete feasibility reports. We can even support you to put in place a distribution solution for your technology in your country.

Strategy - Environment Scan

ENVIRONMENT SCAN

Identification of the state of the art

  • Identification of local or national country-specific market access & health economic issues.
  • Systematic literature review, including published and on-going clinical trials, practice guidelines, health economic evidence & real-life studies.
  • Thorough understanding of the competitive landscape, including the identification of the reimbursable therapeutic and diagnostic alternatives.
  • Coding analysis, with screening & analysis of national health information databases.
  • Continuous monitoring of the market access and regulatory environment during projects.
Strategy - Market Access Investigation

MARKET ACCESS INVESTIGATION

Towards the creation of opportunities

  • Estimation of the potential place of the product in the healthcare strategy, by the identification of unmet needs and associated target populations.
  • Identification of relevant early-funding and reimbursement pathways for each targeted country.
  • Validation of the eligibility of the healthcare solution to each pathway, with a particular focus on clinical, economic and organisational issues.
  • Highlighting of the specific advantages and drawbacks of each eligible market access pathway.
  • Identification of potential reimbursement issues specific to some device categories.
  • Definition of the optimal market access pathways and associated clinical and economic arguments.
Strategy - Risk Assessment

RISK ASSESSMENT & GAP ANALYSIS

Meet the requirements, ensure your success

  • Accurate estimation of the available level of evidence, thanks to a deep knowledge of the statistical methodology of clinical and medico-economic studies.
  • Validation of the transposability of evidence to clinical practice in each targeted country.
  • Assessment of the diffusion and adoption of the product by healthcare professionals.
  • Evidence gap analysis with regards to clinical & economic expectation of healthcare authorities.
  • Identification of all missing clinical & economic data for early-funding or reimbursement.
  • Support on evidence generation, depending on clinical & economic requirements.
  • Risk assessment: identification of the potential country-specific traps and value drivers.
Strategy - Action Plan

CUSTOMIZED ACTION PLAN

Benefit from a high-level strategic study

  • Tailored services, from face-to-face strategic consultations to a complete feasibility report.
  • European mapping with prioritization of the most relevant countries for market entry.
  • Overview of country-specific regulatory steps.
  • Presentation of the market access strategy, with targeted indications and associated arguments.
  • Description and justification of our recommendations and budget/timeline estimations.
  • Full follow-up on the execution of the market access plan.
  • Strategic advice and setting up of a direct distribution solution for the targeted product.

WE DO NOT END THERE.

SEE HOW WE CAN SUPPORT YOU.

Contact us
Strategy
Public Affairs
Pricing & Negotiations
Medical Writing
Training
Due Diligence & Business Development
Health Economics